February 18, 2026 · Form 4 insider transaction
DEC TIMOTHY C bought 3,000 shares of Supernus Pharmaceuticals, Inc. at $0.00 per share, a transaction worth N/A. The trade was recorded as grant or award and disclosed on an SEC Form 4, filed 2 days after the transaction.
Each restricted stock unit represents the right to receive one share of Supernus common stock upon vesting.; These restricted stock units are settled in common stock upon vesting, which occurs in four equal annual installments, beginning on February 18, 2027.